ARK Genomic Revolution ETF(ARKG) Stock Price

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $60
Benzinga12:10 ET · Ratings
Guggenheim Reiterates Buy on Twist Bioscience, Maintains $50 Price Target
BenzingaMay 6 10:21 ET · Ratings
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
BenzingaMay 6 09:13 ET
JP Morgan Maintains Underweight on Twist Bioscience, Lowers Price Target to $33
BenzingaMay 6 07:41 ET · Ratings
Twist Bioscience Analyst Ratings
BenzingaMay 6 07:40 ET · Ratings
Recursion Pharmaceuticals Analyst Ratings
BenzingaMay 6 05:17 ET · Ratings

Comments

10baggerbamm

Feb 27 02:30

$ARK Genomic Revolution ETF (ARKG.US)$ if you're looking for a AI related biotech fund. this ETF has actually done very well it trades pretty consistently between the lower and the upper Bollinger band.
recently everything came down the past 4 days have been god-awful and to know exception this fund took a hit.
if there can be over the next two weeks an upward bias I think you're going to see high 28s maybe touching 29 on this ETF.

2

Cow Moo-ney

Feb 25 21:38

Will we see a bounce today?

S&P 500 is currently on a three-day losing streak, with investors weighing concerns around rising inflation and a potential global trade war.
Even bitcoin is falling. It has dropped below $90K for the first time in 3 months.
Market is feeling a little jittery now?
$KraneShares CSI China Internet ETF (KWEB.US)$ $Trump Media & Technology (DJT.US)$ $GameStop (GME.US)$ $BABA-W (09988.HK)$ $Enphase Energy (ENPH.US)$ $Financial Select Sector SPDR Fund (XLF.US)$ $Lemonade (LMND.US)$ $ARK Innovation ETF (ARKK.US)$
...

https://youtu.be/9ff51xCnyks

From YouTube

7

2

jitter

Feb 5 22:48

$ARK Genomic Revolution ETF (ARKG.US)$ so many fake selling orders, to lure small players to let go at low price. Caution.

Moomoo Learn

Sep 6, 2024 16:05

Columns Navigating the wave of lower interest rates

Given the strong market expectations for a Federal Reserve rate cut, as indicated by the CME data with a 57% chance for a 25-basis-point reduction and a 43% chance for a 50-basis-point cut in September, investors are poised to reconsider their strategies.
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle? Let's delve into the tactics and consid...